Hiroyuki Yoda

Also affiliated with University of California, San Francisco, Chiba Cancer Center, UCSF Helen Diller Family Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “CD55, a potential immunotherapeutic target forMYCN-amplified neuroblastoma”.

CD55, a potential immunotherapeutic target forMYCN-amplified neuroblastoma

Neuro-Oncology(2022)10.1093/neuonc/noac020

N/A

0DataRank · unranked

1 citations

William A. Weiss, Hiroyuki Yoda

ALK upregulates POSTN and WNT signaling to drive neuroblastoma

Cell Reports(2024)10.1016/j.celrep.2024.113927

N/A

0DataRank · unranked

16 citations

Wanqi Fang, Alvin Farrel, Linwei Li, Antonios Chronopoulos, Nicole Nasholm +17 more

EGFR and EGFRvIII coopt host defense pathways promoting progression in glioblastoma

Neuro-Oncology(2024)10.1093/neuonc/noae182

N/A

0DataRank · unranked

11 citations

Qi-Wen Fan, Linyu Wang, Hiroyuki Yoda, Megumi J. Barata, David Jimenez‐Morales +7 more

Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma

The Journal of Experimental Medicine(2025)10.1084/jem.20231417

N/A

0DataRank · unranked

3 citations

Hiroyuki Yoda, Nicole Nasholm, Megumi J. Barata, Linyu Wang, Erin F. Simonds +15 more